4.7 Article

Reliability of the qualitative and semiquantitative nailfold videocapillaroscopy assessment in a systemic sclerosis cohort: a two-centre study

期刊

ANNALS OF THE RHEUMATIC DISEASES
卷 69, 期 6, 页码 1092-1096

出版社

BMJ PUBLISHING GROUP
DOI: 10.1136/ard.2009.115568

关键词

-

资金

  1. Scientific Research-Flanders
  2. Rotary - National Association

向作者/读者索取更多资源

Objective Investigation of the reliability of the qualitative and semiquantitative scoring of nailfold videocapillaroscopy (NVC) assessment between two raters in a systemic sclerosis (SSc) cohort. Methods Two raters from different centres blindly assessed the NVC images of 71 consecutive patients with SSc qualitatively as belonging to the scleroderma spectrum (SDS) category ('early', 'active', 'late' scleroderma pattern or 'scleroderma-like' pattern) or to the 'normal' category and semiquantitatively by calculating the mean score for capillary loss, giant capillaries, microhaemorrhages and capillary ramifications. Inter-rater/intrarater agreement was assessed by calculation of the proportion of agreement and by. coefficients. Rater agreement of mean score values of hallmark parameters was assessed by intraclass correlation coefficients. Results The inter-rater/intrarater proportion of agreement to qualitatively assess an image as belonging to the SDS category or not was 90% and 96%, whereas the agreement to distinguish between only 'early', 'active' and 'late' scleroderma NVC patterns was 62% and 81%. The agreement of the semiquantitative scoring, as assessed by intraclass correlation coefficient, was 0.96 and 0.95 for capillary loss, 0.84 and 0.95 for giant capillaries, 0.90 and 0.95 for microhaemorrhages and 0.64 and 0.95 for capillary ramifications. Conclusions This is the first study to demonstrate reliability of the qualitative and semiquantitative NVC assessment in an SSc cohort between raters at different centres. Reliability of NVC assessment is essential for use of this tool in multicentre SSc trials.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Editorial Material Rheumatology

Acute Perimyocarditis in a Case of Multisystem Inflammatory Syndrome in Adults

Jens T. Van Praet, Pascale De Paepe, Levi Hoste, Filomeen Haerynck

JOURNAL OF RHEUMATOLOGY (2022)

Article Hematology

COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA)

Francesco Marchesi, Jon Salmanton-Garcia, Ziad Emarah, Klara Piukovics, Marcio Nucci, Alberto Lopez-Garcia, Zdenek Racil, Francesca Farina, Marina Popova, Sofia Zompi, Ernesta Audisio, Marie-Pierre Ledoux, Luisa Verga, Barbora Weinbergerova, Tomas Szotkovski, Maria Gomes Da Silva, Nicola Fracchiolla, Nick De Jonge, Graham Collins, Monia Marchetti, Gabriele Magliano, Carolina Garcfa-Vidal, Monika M. Biernat, Jaap Van Doesum, Marina Machado, Fatih Demirkan, Murtadha Al-Khabori, Pavel Zak, Benjamfn Vfsek, Igor Stoma, Gustavo-Adolfo Mendez, Johan Maertens, Nina Khanna, Ildefonso Espigado, Giulia Dragonetti, Luana Fianchi, Maria Ilaria Del Principe, Alba Cabirta, Irati Ormazabal-Velez, Ozren Jaksic, Caterina Buquicchio, Valentina Bonuomo, Josip Batinic, Ali S. Omrani, Sylvain Lamure, Olimpia Finizio, Noemf Fernandez, Iker Falces-Romero, Ola Blennow, Rui Bergantim, Natasha Ali, Sein Win, Jens Van Praet, Maria Chiara Tisi, Ayten Shirinova, Martin Schoenlein, Juergen Prattes, Monica Piedimonte, Verena Petzer, Milan Navratil, Austin Kulasekararaj, Pavel Jindra, Jiff Sramek, Andreas Glenthoj, Rita Fazzi, Cristina De Ramon-Sanchez, Chiara Cattaneo, Maria Calbacho, Nathan C. Bahr, Shaimaa El-Ashwah, Raul Cordoba, Michaela Hanakova, Giovanni Paolo Maria Zambrotta, Giovanni Zambrotta, Mariarita Sciume, Stephen Booth, Raquel Nunes Rodrigues, Maria Vittoria Sacchi, Nicole Garcia-Pouton, Juan-Alberto Martin-Gonzalez, Sofya Khostelidi, Stefanie Graefe, Laman Rahimli, Emanuele Ammatuna, Alessandro Busca, Paolo Corradini, Martin Hoenigl, Nikolai Klimko, Philipp Koehler, Antonio Pagliuca, Francesco Passamonti, Oliver A. Cornely, Livio Pagano

Summary: Patients with acute myeloid leukemia (AML) who are diagnosed with COVID-19 are at high risk of death. The management of AML patients with COVID-19 has not been established. In our study, a significant number of AML patients receiving or having received AML treatment had severe or critical COVID-19. Chemotherapy was modified or discontinued in a substantial portion of patients. The mortality rate was high, and survival was better when AML treatment could be delayed.

HAEMATOLOGICA (2023)

Review Medicine, General & Internal

Infections caused by hypervirulent Klebsiella pneumoniae in non-endemic countries: three case reports and review of the literature

Wannes Van Hooste, Marthe Vanrentergem, Eric Nulens, Christophe Snauwaert, Deborah De Geyter, Rembert Mertens, Jens T. Van Praet

Summary: This study aimed to describe the clinical and microbiological characteristics of hypervirulent Klebsiella pneumoniae infections in non-endemic regions. The results showed that this infection predominantly occurred in middle-aged males and metastatic infections were common. These findings provide important guidance for the diagnosis and treatment of this infection for clinicians.

ACTA CLINICA BELGICA (2023)

Article Hematology

Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey

Livio Pagano, Jon Salmanton-Garcia, Francesco Marchesi, Ola Blennow, Maria Gomes da Silva, Andreas Glenthoj, Jaap van Doesum, Yavuz M. Bilgin, Alberto Lopez-Garcia, Federico Itri, Raquel Nunes Rodrigues, Barbora Weinbergerova, Francesca Farina, Giulia Dragonetti, Caroline Berg Venemyr, Jens van Praet, Ozren Jaksic, Toni Valkovic, Iker Falces-Romero, Sonia Martin-Perez, Moraima Jimenez, Julio Davila-Valls, Martin Schonlein, Emanuele Ammatuna, Stef Meers, Mario Delia, Zlate Stojanoski, Anna Nordlander, Tobias Lahmer, Laszlo Imre Pinczes, Caterina Buquicchio, Klara Piukovics, Irati Ormazabal-Velez, Nicola Fracchiolla, Michail Samarkos, Gustavo-Adolfo Mendez, Jose-Angel Hernandez-Rivas, Ildefonso Espigado, Martin Cernan, Verena Petzer, Sylvain Lamure, Roberta di Blasi, Joyce Marques de Almedia, Michelina Dargenio, Monika M. Biernat, Mariarita Sciume, Cristina de Ramon, Nick de Jonge, Josip Batinic, Avinash Aujayeb, Monia Marchetti, Guillemette Fouquet, Noemi Fernandez, Giovanni Zambrotta, Maria Vittoria Sacchi, Anna Guidetti, Fatih Demirkan, Lucia Prezioso, Zdenek Racil, Marcio Nucci, Milos Mladenovic, Raphael Lievin, Michaela Hanakova, Stefanie Grafe, Uluhan Sili, Marina Machado, Chiara Cattaneo, Tatjana Adzic-Vukicevic, Luisa Verga, Jorge Labrador, Laman Rahimli, Matteo Bonanni, Francesco Passamonti, Antonio Pagliuca, Paolo Corradini, Martin Hoenigl, Philipp Koehler, Alessandro Busca, Oliver A. Cornely

Summary: Limited data are available on breakthrough COVID-19 in patients with hematologic malignancy (HM) after anti-SARS-CoV-2 vaccination. This study found a relatively low mortality rate among patients with breakthrough COVID-19, with the Omicron variant being the predominant strain. Patients receiving monoclonal antibody treatment had a lower mortality rate.
Article Oncology

B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA)

Maria Stefania Infante, Jon Salmanton-Garcia, Ana Fernandez-Cruz, Francesco Marchesi, Ozren Jaksic, Barbora Weinbergerova, Caroline Besson, Rafael F. Duarte, Federico Itri, Toni Valkovic, Tomas Szotkovski, Alessandro Busca, Anna Guidetti, Andreas Glenthoj, Graham P. Collins, Valentina Bonuomo, Uluhan Sili, Guldane Cengiz Seval, Marina Machado, Raul Cordoba, Ola Blennow, Ghaith Abu-Zeinah, Sylvain Lamure, Austin Kulasekararaj, Iker Falces-Romero, Chiara Cattaneo, Jaap Van Doesum, Klara Piukovics, Ali S. Omrani, Gabriele Magliano, Marie-Pierre Ledoux, Cristina de Ramon, Alba Cabirta, Luisa Verga, Alberto Lopez-Garcia, Maria Gomes Da Silva, Zlate Stojanoski, Stef Meers, Tobias Lahmer, Sonia Martin-Perez, Julio Davila-Vals, Jens Van Praet, Michail Samarkos, Yavuz M. Bilgin, Linda Katharina Karlsson, Josip Batinic, Anna Nordlander, Martin Schonlein, Martin Hoenigl, Zdenek Racil, Milos Mladenovic, Michaela Hanakova, Giovanni Paolo Maria Zambrotta, Nick De Jonge, Tatjana Adzic-Vukicevic, Raquel Nunes-Rodrigues, Lucia Prezioso, Milan Navratil, Monia Marchetti, Annarosa Cuccaro, Maria Calbacho, Antonio Giordano, Oliver A. Cornely, Jose-Angel Hernandez-Rivas, Livio Pagano

Summary: Patients with lymphoproliferative diseases treated with targeted drugs have increased severity and mortality from COVID-19. Age, active malignancy, severe COVID-19, and ICU admission are risk factors for mortality. Vaccination can reduce overall mortality rate.

FRONTIERS IN ONCOLOGY (2022)

Letter Hematology

Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Report

Jon Salmanton-Garcia, Francesco Marchesi, Andreas Glenthoj, Yavuz M. Bilgin, Jens van Praet, Julio Davila-Valls, Sonia Martin-Perez, Jorge Labrador, Jaap van Doesum, Iker Falces-Romero, Francesca Farina, Martin Schoenlein, Mathilde Chanut, Verena Petzer, Ildefonso Espigado, Michelina Dargenio, Avinash Aujayeb, Uluhan Sili, Laura Serrano, Laszlo Imre Pinczes, Nick de Jonge, Andres Soto-Silva, Caterina Buquicchio, Lucia Prezioso, Monia Marchetti, Stef Meers, Alessandro Busca, Paolo Corradini, Martin Hoenigl, Philipp Koehler, Laman Rahimli, Gokce Melis Colak, Elena Arellano, Dominik Wolf, Stefanie Graefe, Emanuele Ammatuna, Caroline Berg Venemyr, Oliver A. Cornely, Livio Pagano

HEMASPHERE (2022)

Article Infectious Diseases

Efficacy, durability, and tolerability of bictegravir/emtricitabine/tenofovir alafenamide for the treatment of HIV in a real-world setting in Belgium

Rakan Nasreddine, Eric Florence, Jean Cyr Yombi, Sophie Henrard, Gilles Darcis, Jens Van Praet, Linos D. Vandekerckhove, Sabine Allard, Remy Demeester, Peter Messiaen, Nathalie Ausselet, Marc Delforge, Stephane De Wit

Summary: This study evaluated the effectiveness, durability, and tolerability of BIC/FTC/TAF in treating HIV patients in a real-world setting in Belgium. The results showed that the overall virological suppression rate was 93.5% after 48 weeks, indicating excellent effectiveness and tolerability with rare occurrence of drug resistance.

HIV MEDICINE (2023)

Letter Immunology

Dynamics of Weight Change After Initiation of Contemporaneous Antiretroviral Therapy in Treatment-Naive HIV-1 Infected Patients: Results From the Belgian HIV Cohort 2015-2021

Jens T. Van Praet, Ben Serrien, Nathalie Ausselet, Gilles Darcis, Remy Demeester, Paul De Munter, Marie-Angelique De Scheerder, Jean-Christophe Goffard, Agnes Libois, Peter Messiaen, Jean Cyr Yombi, Dominique Van Beckhoven

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2023)

Letter Oncology

Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry

Francesco Marchesi, Jon Salmanton-Garcia, Caterina Buquicchio, Federico Itri, Caroline Besson, Julio Davila-Valls, Sonia Martin-Perez, Luana Fianchi, Laman Rahimli, Giuseppe Tarantini, Federica Irene Grifoni, Mariarita Sciume, Jorge Labrador, Raul Cordoba, Alberto Lopez-Garcia, Nicola S. Fracchiolla, Francesca Farina, Emanuele Ammatuna, Antonella Cingolani, Daniel Garcia-Bordallo, Stefanie K. Graefe, Yavuz M. Bilgin, Michelina Dargenio, Tomas Jose Gonzalez-Lopez, Anna Guidetti, Tobias Lahmer, Esperanza Lavilla-Rubira, Gustavo-Adolfo Mendez, Lucia Prezioso, Martin Schoenlein, Jaap Van Doesum, Dominik Wolf, Ditte Stampe Hersby, Ferenc Magyari, Jens Van Praet, Verena Petzer, Carlo Tascini, Iker Falces-Romero, Andreas Glenthoj, Oliver A. Cornely, Livio Pagano

Summary: This study reports breakthrough COVID-19 infections in hematologic malignancies patients who received prophylactic tixagevimab/cilgavimab. Most patients had lymphoproliferative disorders and were infected with the omicron variant. The use of tixagevimab/cilgavimab appears to reduce the severity of COVID-19 in these patients, but further studies are needed to determine the optimal drug administration strategies for immunocompromised patients.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2023)

Article Infectious Diseases

Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study

Martin Hoenigl, Jon Salmanton-Garcia, Matthias Egger, Jean-Pierre Gangneux, Tihana Bicanic, Sevtap Arikan-Akdagli, Ana Alastruey-Izquierdo, Nikolai Klimko, Aleksandra Barac, Volkan Ozenci, Eelco F. J. Meijer, Nina Khanna, Matteo Bassetti, Riina Rautemaa-Richardson, Katrien Lagrou, Kai -Manuel Adam, Emin Halis Akalin, Murat Akova, Valentina Arsic Arsenijevic, Avinash Aujayeb, Ola Blennow, Stephane Bretagne, Francois Danion, Blandine Denis, Nick Alexander de Jonge, Guillaume Desoubeaux, Lubos Drgona, Nurettin Erben, Andrea Gori, Julio Garcia Rodriguez, Carolina Garcia-Vidal, Daniele Roberto Giacobbe, Anna L. Goodman, Petr Hamal, Helena Hammarstrom, Cristina Toscano, Fanny Lanternier, Cornelia Lass-Floerl, Deborah E. A. Lockhart, Thomas Longval, Laura Loughlin, Tadeja Matos, Malgorzata Mikulska, Manjusha Narayanan, Sonia Martin-Perez, Juergen Prattes, Benedict Rogers, Laman Rahimli, Maite Ruiz, Emmanuel Roilides, Michael Samarkos, Ulrike Scharmann, Uluhan Sili, Oguz Resat Sipahi, Alena Sivakova, Joerg Steinmann, Janina Trauth, Ozge Turhan, Jens Van Praet, Antonio Vena, P. Lewis White, Birgit Willinger, Anna Maria Tortorano, Maiken C. Arendrup, Philipp Koehler, Oliver A. Cornely

Summary: The European Confederation of Medical Mycology (ECMM) collected data on candidaemia patients in Europe to assess the association between adherence to guideline recommendations and outcomes. The study found that following the recommendations can improve the survival rate of patients.

LANCET INFECTIOUS DISEASES (2023)

Article Genetics & Heredity

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

Daniela Matuozzo, Estelle Talouarn, Astrid Marchal, Peng Zhang, Jeremy Manry, Yoann Seeleuthner, Yu Zhang, Alexandre Bolze, Matthieu Chaldebas, Baptiste Milisavljevic, Adrian Gervais, Paul Bastard, Takaki Asano, Lucy Bizien, Federica Barzaghi, Hassan Abolhassani, Ahmad Abou Tayoun, Alessandro Aiuti, Ilad Alavi Darazam, Luis M. Allende, Rebeca Alonso-Arias, Andres Augusto Arias, Gokhan Aytekin, Peter Bergman, Simone Bondesan, Yenan T. Bryceson, Ingrid G. Bustos, Oscar Cabrera-Marante, Sheila Carcel, Paola Carrera, Giorgio Casari, Khalil Chaibi, Roger Colobran, Antonio Condino-Neto, Laura E. Covill, Ottavia M. Delmonte, Loubna El Zein, Carlos Flores, Peter K. Gregersen, Marta Gut, Filomeen Haerynck, Rabih Halwani, Selda Hancerli, Lennart Hammarstroem, Nevin Hatipoglu, Adem Karbuz, Sevgi Keles, Christele Kyheng, Rafael Leon-Lopez, Jose Luis Franco, Davood Mansouri, Javier Martinez-Picado, Ozge Metin Akcan, Isabelle Migeotte, Pierre-Emmanuel Morange, Guillaume Morelle, Andrea Martin-Nalda, Giuseppe Novelli, Antonio Novelli, Tayfun Ozcelik, Figen Palabiyik, Qiang Pan-Hammarstroem, Rebeca Perez de Diego, Laura Planas-Serra, Daniel E. Pleguezuelo, Carolina Prando, Aurora Pujol, Luis Felipe Reyes, Jacques G. Riviere, Carlos Rodriguez-Gallego, Julian Rojas, Patrizia Rovere-Querini, Agatha Schlueter, Mohammad Shahrooei, Ali Sobh, Pere Soler-Palacin, Yacine Tandjaoui-Lambiotte, Imran Tipu, Cristina Tresoldi, Jesus Troya, Diederik van de Beek, Mayana Zatz, Pawel Zawadzki, Saleh Zaid Al-Muhsen, Mohammed Faraj Alosaimi, Fahad M. Alsohime, Hagit Baris-Feldman, Manish J. Butte, Stefan N. Constantinescu, Megan A. Cooper, Clifton L. Dalgard, Jacques Fellay, James R. Heath, Yu-Lung Lau, Richard P. Lifton, Tom Maniatis, Trine H. Mogensen, Horst von Bernuth, Alban Lermine, Michel Vidaud, Anne Boland, Jean-Francois Deleuze, Robert Nussbaum, Amanda Kahn-Kirby, France Mentre, Sarah Tubiana, Guy Gorochov, Florence Tubach, Pierre Hausfater, C. O. V. I. D. Human Genetic Effort, Isabelle Meyts, Shen-Ying Zhang, Anne Puel, Luigi D. Notarangelo, Stephanie Boisson-Dupuis, Helen C. Su, Bertrand Boisson, Emmanuelle Jouanguy, Jean-Laurent Casanova, Qian Zhang, Laurent Abel, Aurelie Cobat

Summary: Through a genome-wide rare variant burden association analysis, it was found that there is an association between at-risk variants in the TLR7 gene and rare loss-of-function variants in TLR3-dependent type I interferon immunity genes. These findings suggest that rare variants in TLR3- and TLR7-dependent type I interferon immunity genes may underlie life-threatening COVID-19 in patients under 60 years old.

GENOME MEDICINE (2023)

Article Immunology

Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry

Alessandro Busca, Jon Salmanton-Garcia, Francesco Marchesi, Francesca Farina, Guldane Cengiz Seval, Jaap Van Doesum, Nick C. De Jonge, Nathan C. Bahr, Johan Maertens, Joseph S. Meletiadis, Nicola S. Fracchiolla, Barbora Weinbergerova, Luisa Verga, Zdenek Racil, Moraima Jimenez, Andreas Glenthoj, Ola Blennow, Alina Daniela Tanase, Martin Schoenlein, Lucia Prezioso, Nina F. Khanna, Rafael F. Duarte, Pavel Zak, Marcio Nucci, Marina Machado, Austin Kulasekararaj, Ildefonso Espigado, Elizabeth De Kort, Jose-Maria Ribera-Santa Susana, Monia Marchetti, Gabriele Magliano, Iker Falces-Romero, Osman Ilhan, Emanuele Ammatuna, Sofia Zompi, Panagiotis Tsirigotis, Anastasia Antoniadou, Giovanni Paolo Maria Zambrotta, Anna Nordlander, Linda Katharina Karlsson, Michaela Hanakova, Giulia Dragonetti, Alba Cabirta, Caroline Berg Venemyr, Stefanie Graefe, Jens Van Praet, Athanasios Tragiannidis, Verena Petzer, Alberto Lopez-Garcia, Federico Itri, Ana Groh, Eleni Gavriilaki, Michelina Dargenio, Laman A. Rahimli, Oliver A. Cornely, Livio Pagano

Summary: This multicenter retrospective study analyzed the outcome and risk factors for mortality in 326 adult HSCT patients who developed COVID-19. The results showed that age, comorbidities, active hematologic disease, timing from transplant, and severity of the infection were associated with a higher risk of mortality. The overall mortality rate was 21%, with COVID-19 being the main or secondary cause of death in 16% of the patients.

FRONTIERS IN IMMUNOLOGY (2023)

Article Hematology

Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post-CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey

Jaap A. van Doesum, Jon Salmanton-Garcia, Francesco Marchesi, Roberta Di Blasi, Iker Falces-Romero, Alba Cabirta, Francesca Farina, Caroline Besson, Barbora Weinbergerova, Jens Van Praet, Martin Schoenlein, Alberto Lopez-Garcia, Sylvain Lamure, Anna Guidetti, Cristina De Ramon-Sanchez, Josip Batinic, Eleni Gavriilaki, Athanasios Tragiannidis, Maria Chiara Tisi, Gaetan Plantefeve, Verena Petzer, Irati Ormazabal-Velez, Joyce Marques de Almeida, Monia Marchetti, Johan Maertens, Marina Machado, Austin Kulasekararaj, Jose-angel Hernandez-Rivas, Maria Gomes da Silva, Noemi Fernandez, Ildefonso Espigado, Lubos Drgona, Giulia Dragonetti, Elisabetta Metafuni, Maria Calbacho, Ola Blennow, Dominik Wolf, Bjorn van Anrooij, Raquel Nunes Rodrigues, Anna Nordlander, Juan-Alberto Martin-Gonzalez, Raphael Lievin, Moraima Jimenez, Stefanie K. Grafe, Ramon Garcia-Sanz, Raul Cordoba, Laman Rahimli, Tom van Meerten, Oliver A. Cornely, Livio Pagano

Summary: Patients with previous CD19-directed CAR T-cell therapy have a higher susceptibility to viral infections, including COVID-19. However, this study finds that COVID-19 mortality rates in these patients have improved over time, especially with the Omicron variant having a significantly lower death risk. Prior vaccination and monoclonal antibody treatment also contribute to reducing mortality and mitigating the severity of the disease.

BLOOD ADVANCES (2023)

Article Medicine, General & Internal

Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry

Jon Salmanton-Garcia, Francesco Marchesi, Maria Gomes da Silva, Francesca Farina, Julio Davila-Valls, Yavuz M. Bilgin, Andreas Glenthoj, Iker Falces-Romero, Jaap Van Doesum, Jorge Labrador, Caterina Buquicchio, Shaimaa El-Ashwah, Verena Petzer, Jens Van Praet, Martin Schoenlein, Michelina Dargenio, Gustavo-Adolfo Mendez, Stef Meers, Federico Itri, Antonio Giordano, Laszlo Imre Pinczes, Ildefonso Espigado, Zlate Stojanoski, Alberto Lopez-Garcia, Lucia Prezioso, Ozren Jaksic, Antonio Vena, Nicola S. Fracchiolla, Tomas Jose Gonzalez-Lopez, Natasa Colovic, Mario Delia, Barbora Weinbergerova, Monia Marchetti, Joyce Marques de Almeida, Olimpia Finizio, Caroline Besson, Monika M. Biernat, Toni Valkovic, Tobias Lahmer, Annarosa Cuccaro, Irati Ormazabal-Velez, Josip Batinic, Noemi Fernandez, Nick De Jonge, Carlo Tascini, Amalia N. Anastasopoulou, Remy Dulery, Maria Ilaria Del Principe, Gaetan Plantefeve, Mario Virgilio Papa, Marcio Nucci, Moraima Jimenez, Avinash Aujayeb, Jose-angel Hernandez-Rivas, Maria Merelli, Chiara Cattaneo, Ola Blennow, Anna Nordlander, Alba Cabirta, Gina Varricchio, Maria Vittoria Sacchi, Raul Cordoba, Elena Arellano, Stefanie K. Grafe, Dominik Wolf, Ziad Emarah, Emanuele Ammatuna, Ditte Stampe Hersby, Sonia Martin-Perez, Raquel Nunes Rodrigues, Laman Rahimli, Livio Pagano, Oliver A. Cartney

Summary: Nirmatrelvir/ritonavir treatment is associated with lower mortality in hematological malignancy patients. The treatment is related to the presence of extra-pulmonary symptoms and vaccination status for COVID-19, but not chronic pulmonary disease or obesity.

ECLINICALMEDICINE (2023)

Article Mycology

Predictors for Prolonged Hospital Stay Solely to Complete Intravenous Antifungal Treatment in Patients with Candidemia: Results from the ECMM Candida III Multinational European Observational Cohort Study

Matthias Egger, Jon Salmanton-Garcia, Aleksandra Barac, Jean-Pierre Gangneux, Helene Guegan, Valentina Arsic-Arsenijevic, Tadeja Matos, Rok Tomazin, Nikolai Klimko, Matteo Bassetti, Helena Hammarstroem, Eelco F. J. Meijer, Jacques F. Meis, Juergen Prattes, Robert Krause, Oguz Resat Sipahi, Ulrike Scharmann, P. Lewis White, Guillaume Desoubeaux, Julio Garcia-Rodriguez, Carolina Garcia-Vidal, Sonia Martin-Perez, Maite Ruiz, Mario Tumbarello, Alida Fe Talento, Benedict Rogers, Katrien Lagrou, Jens van Praet, Sevtap Arikan-Akdagli, Maiken C. Arendrup, Philipp Koehler, Oliver A. Cornely, Martin Hoenigl

Summary: This sub-analysis of the Candida III study investigated the demographical and clinical characteristics of patients with candidemia who required prolonged hospitalization for completion of intravenous antifungal treatment. The study found that the use of initial echinocandin treatment was associated with prolonged hospital stay, while factors such as neutropenia, intensive care unit admission, catheter related candidemia, total parenteral nutrition, and C. parapsilosis infection were associated with shorter hospitalization.

MYCOPATHOLOGIA (2023)

暂无数据